Update: 30.12.2022
Last week: 51 week 2022 (19.12.2022 - 25.12.2022)
Last full month: November 2022
| Time period | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| BROMHEXINE BERLIN-CHEMIE | |||||||||
| WoW | 190 492 | -16.5% | 2.9% | -0.3 | 47 172 496 | -13.3% | 3.3% | -0.2 | -7.4% |
| MoM | 604 970 | -8.8% | 3.3% | -0.5 | 138 517 736 | -2.4% | 3.4% | -0.4 | 4.9% |
| YTD | 9 691 090 | -25.5% | 4.8% | -1.6 | 1 980 547 332 | -11.6% | 4.7% | -1.1 | -1.5% |
| MAT | 9 954 774 | -24.5% | 4.9% | -1.4 | 2 030 191 704 | -10.7% | 4.7% | -0.9 | -3.2% |
| DEXALGIN | |||||||||
| WoW | 21 006 | 8.7% | 0.4% | 0 | 10 277 877 | 12.4% | 1.2% | 0.2 | -6.3% |
| MoM | 67 963 | -21.8% | 0.3% | -0.1 | 33 907 140 | -21.4% | 1.1% | -0.3 | -3.7% |
| YTD | 1 563 791 | -13.2% | 0.6% | -0.1 | 675 702 618 | -1.5% | 1.7% | -0.2 | -0.1% |
| MAT | 1 601 886 | -14.0% | 0.6% | -0.1 | 690 586 310 | -2.6% | 1.7% | -0.2 | -1.8% |
| ESPUMISAN (ADULTS) | |||||||||
| WoW | 52 498 | -6.1% | 40.6% | -1.4 | 31 312 406 | -4.7% | 49.1% | -1.2 | -2.9% |
| MoM | 240 711 | 0.5% | 41.3% | -1.5 | 131 026 847 | 4.0% | 48.3% | -0.8 | 4.1% |
| YTD | 4 232 687 | -18.4% | 53.3% | -12.8 | 2 177 340 388 | -8.5% | 59.0% | -11.5 | 1.1% |
| MAT | 4 326 641 | -19.2% | 53.4% | -12.5 | 2 222 243 314 | -9.3% | 59.1% | -11.3 | -0.3% |
| ESPUMISAN BABY | |||||||||
| WoW | 21 864 | -1.9% | 31.1% | 0.1 | 15 801 516 | -0.5% | 46.7% | 0.2 | -2.1% |
| MoM | 103 328 | 2.6% | 33.8% | 1.4 | 69 479 607 | 5.8% | 47.4% | 1.6 | -1.6% |
| YTD | 1 404 984 | -14.1% | 37.0% | -4.4 | 890 133 492 | -6.8% | 50.4% | -5.8 | -4.0% |
| MAT | 1 433 051 | -15.7% | 37.1% | -4.3 | 906 597 640 | -8.6% | 50.5% | -5.7 | -5.8% |
| FASTUM | |||||||||
| WoW | 14 364 | -10.0% | 0.8% | -0.1 | 8 096 093 | -12.4% | 2.1% | -0.2 | -2.4% |
| MoM | 72 086 | 12.1% | 0.9% | 0.1 | 40 966 576 | 12.7% | 2.4% | 0.3 | -1.3% |
| YTD | 1 025 521 | -24.8% | 1.1% | -0.4 | 537 787 495 | -14.6% | 2.5% | -0.6 | 0.1% |
| MAT | 1 046 943 | -26.1% | 1.1% | -0.4 | 548 106 813 | -16.1% | 2.5% | -0.6 | -1.6% |
| IODOMARIN | |||||||||
| WoW | 64 517 | -4.4% | 21.9% | 0.8 | 11 802 739 | -4.6% | 8.5% | 0.2 | -7.9% |
| MoM | 299 606 | -16.4% | 23.2% | -1 | 55 472 593 | -16.2% | 9.8% | -0.8 | -12.7% |
| YTD | 3 235 467 | 4.3% | 20.5% | 0 | 629 326 394 | 8.4% | 9.1% | -0.3 | 4.4% |
| MAT | 3 299 649 | 4.1% | 20.6% | 0.3 | 641 157 311 | 8.0% | 9.1% | -0.2 | 2.8% |
| LIOTON | |||||||||
| WoW | 14 449 | -14.0% | 1.5% | -0.2 | 16 854 625 | -18.7% | 3.9% | -0.7 | -4.5% |
| MoM | 72 321 | 5.9% | 1.8% | 0.2 | 83 457 879 | 9.9% | 4.3% | 0.5 | -4.0% |
| YTD | 1 237 314 | -25.9% | 2.2% | -0.6 | 1 290 105 442 | -6.7% | 4.6% | -1 | -7.5% |
| MAT | 1 259 871 | -26.7% | 2.2% | -0.5 | 1 310 018 305 | -7.8% | 4.6% | -1 | -8.8% |
| MEZYM | |||||||||
| WoW | 226 583 | 0.8% | 18.5% | 0.8 | 33 956 229 | 1.1% | 12.5% | 0.1 | -3.3% |
| MoM | 921 273 | 0.0% | 18.4% | -0.3 | 136 606 124 | -2.7% | 12.9% | -0.6 | 1.9% |
| YTD | 17 051 504 | -16.0% | 25.5% | -3.6 | 2 600 340 200 | -8.5% | 18.2% | -3.5 | -4.3% |
| MAT | 17 505 907 | -17.2% | 25.6% | -3.5 | 2 666 875 608 | -9.8% | 18.3% | -3.5 | -5.9% |
| MIG 400 | |||||||||
| WoW | 144 445 | -4.5% | 2.4% | 0 | 17 940 805 | -2.7% | 2.0% | 0 | -6.3% |
| MoM | 558 202 | -5.5% | 2.8% | -0.1 | 67 227 770 | -5.7% | 2.2% | -0.1 | -3.7% |
| YTD | 8 252 669 | -15.2% | 3.2% | -0.6 | 976 042 803 | -11.1% | 2.5% | -0.6 | -0.1% |
| MAT | 8 416 951 | -16.1% | 3.2% | -0.5 | 994 947 269 | -12.1% | 2.5% | -0.6 | -1.8% |
| PROSTAMOL | |||||||||
| WoW | 22 609 | -6.1% | 13.3% | -0.4 | 31 927 486 | -5.7% | 14.3% | -0.6 | -3.5% |
| MoM | 101 766 | -2.9% | 14.1% | -1.3 | 140 977 526 | -2.3% | 14.9% | -1.4 | 6.2% |
| YTD | 1 525 398 | -27.6% | 18.2% | -6.4 | 2 134 742 786 | -19.6% | 19.4% | -7.4 | -2.0% |
| MAT | 1 558 771 | -28.4% | 18.3% | -6.3 | 2 178 703 618 | -20.5% | 19.5% | -7.2 | -3.7% |
| RESPERO MYRTOL | |||||||||
| WoW | 41 164 | 1.1% | 9.1% | 0.8 | 21 906 150 | 4.7% | 10.1% | 1.1 | -7.8% |
| MoM | 102 019 | 2.1% | 7.0% | -0.6 | 51 471 720 | 5.2% | 7.5% | -0.4 | 11.1% |
| YTD | 1 269 614 | 76.2% | 8.3% | 3.3 | 606 347 631 | 81.9% | 8.5% | 3.2 | 6.1% |
| MAT | 1 295 831 | 76.8% | 8.3% | 3.4 | 617 834 319 | 82.2% | 8.4% | 3.3 | 4.4% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| BROMHEXINE B-CH | 9 691 090 | -25.5% | 4.8% | -1.6 | 1 980 547 332 | -11.6% | 4.7% | -1.1 | -1.5% |
| DEXALGIN | 1 563 791 | -13.2% | 0.6% | -0.1 | 675 702 618 | -1.5% | 1.7% | -0.2 | -0.1% |
| ESPUMISAN (ADULTS) | 4 232 687 | -18.4% | 53.3% | -12.8 | 2 177 340 388 | -8.5% | 59.0% | -11.5 | 1.1% |
| ESPUMISAN BABY | 1 404 984 | -14.1% | 37.0% | -4.4 | 890 133 492 | -6.8% | 50.4% | -5.8 | -4.0% |
| FASTUM | 1 025 521 | -24.8% | 1.1% | -0.4 | 537 787 495 | -14.6% | 2.5% | -0.6 | 0.1% |
| IODOMARIN | 3 235 467 | 4.3% | 20.5% | 0 | 629 326 394 | 8.4% | 9.1% | -0.3 | 4.4% |
| LIOTON | 1 237 314 | -25.9% | 2.2% | -0.6 | 1 290 105 442 | -6.7% | 4.6% | -1 | -7.5% |
| MEZYM | 17 051 504 | -16.0% | 25.5% | -3.6 | 2 600 340 200 | -8.5% | 18.2% | -3.5 | -4.3% |
| MIG 400 | 8 252 669 | -15.2% | 3.2% | -0.6 | 976 042 803 | -11.1% | 2.5% | -0.6 | -0.1% |
| PROSTAMOL | 1 525 398 | -27.6% | 18.2% | -6.4 | 2 134 742 786 | -19.6% | 19.4% | -7.4 | -2.0% |
| RESPERO MYRTOL | 1 269 614 | 76.2% | 8.3% | 3.3 | 606 347 631 | 81.9% | 8.5% | 3.2 | 6.1% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| BROMHEXINE B-CH | 9 954 774 | -24.5% | 4.9% | -1.4 | 2 030 191 704 | -10.7% | 4.7% | -0.9 | -3.2% |
| DEXALGIN | 1 601 886 | -14.0% | 0.6% | -0.1 | 690 586 310 | -2.6% | 1.7% | -0.2 | -1.8% |
| ESPUMISAN (ADULTS) | 4 326 641 | -19.2% | 53.4% | -12.5 | 2 222 243 314 | -9.3% | 59.1% | -11.3 | -0.3% |
| ESPUMISAN BABY | 1 433 051 | -15.7% | 37.1% | -4.3 | 906 597 640 | -8.6% | 50.5% | -5.7 | -5.8% |
| FASTUM | 1 046 943 | -26.1% | 1.1% | -0.4 | 548 106 813 | -16.1% | 2.5% | -0.6 | -1.6% |
| IODOMARIN | 3 299 649 | 4.1% | 20.6% | 0.3 | 641 157 311 | 8.0% | 9.1% | -0.2 | 2.8% |
| LIOTON | 1 259 871 | -26.7% | 2.2% | -0.5 | 1 310 018 305 | -7.8% | 4.6% | -1 | -8.8% |
| MEZYM | 17 505 907 | -17.2% | 25.6% | -3.5 | 2 666 875 608 | -9.8% | 18.3% | -3.5 | -5.9% |
| MIG 400 | 8 416 951 | -16.1% | 3.2% | -0.5 | 994 947 269 | -12.1% | 2.5% | -0.6 | -1.8% |
| PROSTAMOL | 1 558 771 | -28.4% | 18.3% | -6.3 | 2 178 703 618 | -20.5% | 19.5% | -7.2 | -3.7% |
| RESPERO MYRTOL | 1 295 831 | 76.8% | 8.3% | 3.4 | 617 834 319 | 82.2% | 8.4% | 3.3 | 4.4% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| BROMHEXINE B-CH | 190 492 | -16.5% | 2.9% | -0.3 | 47 172 496 | -13.3% | 3.3% | -0.2 | -7.4% |
| DEXALGIN | 21 006 | 8.7% | 0.4% | 0 | 10 277 877 | 12.4% | 1.2% | 0.2 | -6.3% |
| ESPUMISAN (ADULTS) | 52 498 | -6.1% | 40.6% | -1.4 | 31 312 406 | -4.7% | 49.1% | -1.2 | -2.9% |
| ESPUMISAN BABY | 21 864 | -1.9% | 31.1% | 0.1 | 15 801 516 | -0.5% | 46.7% | 0.2 | -2.1% |
| FASTUM | 14 364 | -10.0% | 0.8% | -0.1 | 8 096 093 | -12.4% | 2.1% | -0.2 | -2.4% |
| IODOMARIN | 64 517 | -4.4% | 21.9% | 0.8 | 11 802 739 | -4.6% | 8.5% | 0.2 | -7.9% |
| LIOTON | 14 449 | -14.0% | 1.5% | -0.2 | 16 854 625 | -18.7% | 3.9% | -0.7 | -4.5% |
| MEZYM | 226 583 | 0.8% | 18.5% | 0.8 | 33 956 229 | 1.1% | 12.5% | 0.1 | -3.3% |
| MIG 400 | 144 445 | -4.5% | 2.4% | 0 | 17 940 805 | -2.7% | 2.0% | 0 | -6.3% |
| PROSTAMOL | 22 609 | -6.1% | 13.3% | -0.4 | 31 927 486 | -5.7% | 14.3% | -0.6 | -3.5% |
| RESPERO MYRTOL | 41 164 | 1.1% | 9.1% | 0.8 | 21 906 150 | 4.7% | 10.1% | 1.1 | -7.8% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| BROMHEXINE B-CH | 604 970 | -8.8% | 3.3% | -0.5 | 138 517 736 | -2.4% | 3.4% | -0.4 | 4.9% |
| DEXALGIN | 67 963 | -21.8% | 0.3% | -0.1 | 33 907 140 | -21.4% | 1.1% | -0.3 | -3.7% |
| ESPUMISAN (ADULTS) | 240 711 | 0.5% | 41.3% | -1.5 | 131 026 847 | 4.0% | 48.3% | -0.8 | 4.1% |
| ESPUMISAN BABY | 103 328 | 2.6% | 33.8% | 1.4 | 69 479 607 | 5.8% | 47.4% | 1.6 | -1.6% |
| FASTUM | 72 086 | 12.1% | 0.9% | 0.1 | 40 966 576 | 12.7% | 2.4% | 0.3 | -1.3% |
| IODOMARIN | 299 606 | -16.4% | 23.2% | -1 | 55 472 593 | -16.2% | 9.8% | -0.8 | -12.7% |
| LIOTON | 72 321 | 5.9% | 1.8% | 0.2 | 83 457 879 | 9.9% | 4.3% | 0.5 | -4.0% |
| MEZYM | 921 273 | 0.0% | 18.4% | -0.3 | 136 606 124 | -2.7% | 12.9% | -0.6 | 1.9% |
| MIG 400 | 558 202 | -5.5% | 2.8% | -0.1 | 67 227 770 | -5.7% | 2.2% | -0.1 | -3.7% |
| PROSTAMOL | 101 766 | -2.9% | 14.1% | -1.3 | 140 977 526 | -2.3% | 14.9% | -1.4 | 6.2% |
| RESPERO MYRTOL | 102 019 | 2.1% | 7.0% | -0.6 | 51 471 720 | 5.2% | 7.5% | -0.4 | 11.1% |
ОБОЗНАЧЕНИЯ
WoW - Week Over Week - показатели для сравнения результатов текущей и предыдущей недели
MoM - Month Over Month - показатели для сравнения результатов последнего полного месяца и предыдущего полного месяца
YTD - Year to Date - показатели для сравнения результатов за период времени, начинающийся с первого дня текущего календарного года до текущей даты с результатами за сопоставимый период прошлого года
MAT - Moving Annual Total - показатели для сравнения результатов за период 12 месяцев, с датой окончания на последней доступной неделе, с результатами за сопоставимый период прошлого года
MS - Market Share - Доля рынка = (Продажи бренда / Продажи категории)*100%
Change, % = (Продажи бренда за последний период / Продажи бренда за предыдущий период - 1)*100%
Change, p.p. = Доля бренда на рынке за последний период - Доля бренда на рынке за предыдущий период (выражается в процентных пунктах)
Cat. Volume Change, % = (Продажи категории в упаковках за последний период / Продажи категории в упаковках за предыдущий период - 1)*100%
Каждая категория собрана специально для каждого бренда и включает в себя бренд и его конкурентов
Список конкурентов можно найти в разделе "MS of competitors" в блоке каждого бренда
ABBREVIATIONS
WoW - Week Over Week - indicators for comparing the results of the current and previous week
MoM - Month Over Month - indicators for comparing the results of the* last full month* and previous full month
YTD - Year to Date - indicators for comparing the results of the period of time beginning the first day of the current calendar year up to the current date with the results of the comparable period last year
MAT - Moving Annual Total - indicators for comparing the results of the period, being 12 month period ending on the last week with the results of the comparable period last year
MS - Market Share - (Brand Sales / Category Sales)*100%
Change, % = (Brand Sales of the last period / Brand Sales of the previous period - 1)*100%
Change, p.p. = Brand Market Share of the last period - Brand Market Share of the previous period (expressed in percentage points)
Cat. Volume Change, % = (Category Sales in packs of the last period / Category Sales in packs of the previous period - 1)*100%
Each category is created specifically for each brand and includes the brand and its competitors
The list of competitors can be found in the subsection "MS of competitors" in sections for each brand
## [1] "BROMHEXINE B-CH"
## [1] "BROMHEXINE B-CH COATED TABLETS 8 MG #25"
## [1] "BROMHEXINE B-CH SOL ORAL 4 MG/5 ML 60 ML #1"
## [1] "ESPUMISAN (ADULTS)"
## [1] "ESPUMISAN (ADULTS) CAPS 40 MG #25"
## [1] "ESPUMISAN (ADULTS) CAPS 40 MG #50"
## [1] "ESPUMISAN (ADULTS) EXTRA GRAN 125 MG #14"
## [1] "ESPUMISAN (ADULTS) L EMULS ORAL 40 MG 30 ML #1"
## [1] "ESPUMISAN BABY"
## [1] "ESPUMISAN BABY ORAL DROPS 100 MG/ML 30 ML #1"
## [1] "ESPUMISAN BABY ORAL DROPS 100 MG/ML 50 ML #1"
## [1] "FASTUM"
## [1] "FASTUM GEL FOR EXT USE 2,5% 100 G #1"
## [1] "FASTUM GEL FOR EXT USE 2,5% 30 G #1"
## [1] "FASTUM GEL FOR EXT USE 2,5% 50 G #1"
## [1] "LIOTON"
## [1] "LIOTON 1000 GEL FOR EXT USE 1000 IU/G 100 G #1"
## [1] "LIOTON 1000 GEL FOR EXT USE 1000 IU/G 30 G #1"
## [1] "LIOTON 1000 GEL FOR EXT USE 1000 IU/G 50 G #1"
## [1] "MEZYM"
## [1] "MEZYM 20000 INTESTINAL-SOLUBLE COATED TABLETS #20"
## [1] "MEZYM FORTE COATED TABLETS #20"
## [1] "MEZYM FORTE COATED TABLETS #80"
## [1] "MEZYM NEO 10000 CAPS ENTEROSOLUB 10000 IU #20"
## [1] "MEZYM NEO 10000 CAPS ENTEROSOLUB 10000 IU #50"
## [1] "MEZYM NEO 25000 CAPS ENTEROSOLUB 25000 IU #20"
## [1] "MEZYM NEO 25000 CAPS ENTEROSOLUB 25000 IU #50"
## [1] "MEZYM PRO INTESTINAL-SOLUBLE COATED TABLETS #20"
## [1] "DEXALGIN"
## [1] "DEXALGIN 25 COATED TABLETS 25 MG #10"
## [1] "MIG 400"
## [1] "MIG 400 COATED TABLETS 400 MG #10"
## [1] "MIG 400 COATED TABLETS 400 MG #20"
## [1] "PROSTAMOL"
## [1] "PROSTAMOL UNO CAPS 320 MG #30"
## [1] "PROSTAMOL UNO CAPS 320 MG #60"
## [1] "PROSTAMOL UNO CAPS 320 MG #90"
## [1] "IODOMARIN"
## [1] "IODOMARIN 100 TABS 100 MCG #100"
## [1] "IODOMARIN 200 TABS 200 MCG #100"
## [1] "IODOMARIN 200 TABS 200 MCG #50"
## [1] "IODOMARIN FOR THE FUTURE MOTHER TABLETS 140 MG #30"
## [1] "RESPERO MYRTOL"
## [1] "RESPERO MYRTOL CAPS ENTEROSOLUB 120 MG #20"
## [1] "RESPERO MYRTOL FORTE CAPS ENTEROSOLUB 300 MG #20"
[RUS] ОБОЗНАЧЕНИЯ
WoW - Week Over Week - показатели для сравнения результатов текущей и предыдущей недели
MoM - Month Over Month - показатели для сравнения результатов последнего полного месяца и предыдущего полного месяца
YTD - Year to Date - показатели для сравнения результатов за период времени, начинающийся с первого дня текущего календарного года до текущей даты с результатами за сопоставимый период прошлого года
MAT - Moving Annual Total - показатели для сравнения результатов за период 12 месяцев, с датой окончания на последней доступной неделе, с результатами за сопоставимый период прошлого года
MS - Market Share - Доля рынка = (Продажи бренда / Продажи категории)*100%
Change, % = (Продажи бренда за последний период / Продажи бренда за предыдущий период - 1)*100%
Change, p.p. = Доля бренда на рынке за последний период - Доля бренда на рынке за предыдущий период (выражается в процентных пунктах)
Cat. Volume Change, % = (Продажи категории в упаковках за последний период / Продажи категории в упаковках за предыдущий период - 1)*100%
Каждая категория собрана специально для каждого бренда и включает в себя бренд и его конкурентов
Список конкурентов можно найти в разделе "MS of competitors" в блоке каждого бренда
[ENG] ABBREVIATIONS
WoW - Week Over Week - indicators for comparing the results of the current and previous week
MoM - Month Over Month - indicators for comparing the results of the last full month and previous full month
YTD - Year to Date - indicators for comparing the results of the period of time beginning the first day of the current calendar year up to the current date with the results of the comparable period last year
MAT - Moving Annual Total - indicators for comparing the results of the period, being 12 month period ending on the last week with the results of the comparable period last year
MS - Market Share - (Brand Sales / Category Sales)*100%
Change, % = (Brand Sales of the last period / Brand Sales of the previous period - 1)*100%
Change, p.p. = Brand Market Share of the last period - Brand Market Share of the previous period (expressed in percentage points)
Cat. Volume Change, % = (Category Sales in packs of the last period / Category Sales in packs of the previous period - 1)*100%
Each category is created specifically for each brand and includes the brand and its competitors
The list of competitors can be found in the subsection "MS of competitors" in sections for each brand
DATA SOURCES:
DSM: Sales
Palomars: TRPs
MI: Fact Digital Costs
MI Estimated Costs: TV costs